Wird geladen...
Pediatric Depression Treatment in the Aftermath of the Black Box Warning: Implications for Prescription Drug Policy
In 2004, the Food and Drug Administration (FDA) directed pharmaceutical manufacturers to add a black box warning to antidepressants describing an increased suicide risk in children. We describe the events and evidence that led the FDA to act, the specific actions taken by the agency, and the changes...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768536/ https://ncbi.nlm.nih.gov/pubmed/19414881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.28.3.724 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|